He analysis everything and gives you his opinion. Some here thought that svacf would go from $119M to $355M on Frost merger. It ended up at $75M, thank god Billy was warning the biotech clowns like arlo and dk1949. They lost their shirts.
Any link to the Duke trial and the date of July 25,2018? When i listen to the 60 minute piece they clearly state that the license was with a start up. So we know it's not one of the big name pharmas and that makes sense. If this is a billion dollar drug, they want the potential appreciation to be tied to a $4 stock, instead of a multiple billion dollar stock.